Pages that link to "Q34376852"

The following pages link to Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor (Q34376852):

Displaying 50 items.

• Molecular and biotechnological aspects of microbial proteases (Q24548591) (← links)
• Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides (Q24627225) (← links)
• Active human immunodeficiency virus protease is required for viral infectivity (Q24647696) (← links)
• Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A (Q24649411) (← links)
• Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance (Q27628785) (← links)
• Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography (Q27654045) (← links)
• Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 (Q27702268) (← links)
• The aspartic proteases (Q28208915) (← links)
• Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells (Q28318483) (← links)
• Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues (Q28323197) (← links)
• Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line (Q28335088) (← links)
• Inhibitors of HIV-1 Protease (Q28342785) (← links)
• Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors (Q28355570) (← links)
• Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease (Q28360614) (← links)
• In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor (Q28369528) (← links)
• Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates (Q28378646) (← links)
• Efficacy of constant infusion of A-77003, an inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease, in limiting acute HIV-1 infection in vitro (Q28378785) (← links)
• Gag-Pol processing during HIV-1 virion maturation: a systems biology approach (Q28533696) (← links)
• Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation (Q28590454) (← links)
• Nucleotide sequence and genomic organization of feline immunodeficiency virus (Q30011272) (← links)
• The central domain of the matrix protein of HIV-1: influence on protein structure and virus infectivity. (Q30341481) (← links)
• Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. (Q30452154) (← links)
• Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease (Q30480872) (← links)
• Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis (Q30855134) (← links)
• Understanding HIV-1 protease autoprocessing for novel therapeutic development (Q33356201) (← links)
• Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance (Q33592125) (← links)
• Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli (Q33703756) (← links)
• Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein (Q33750683) (← links)
• Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation (Q33815810) (← links)
• Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease (Q33843249) (← links)
• HIV protease as a target for retrovirus vector-mediated gene therapy (Q33857478) (← links)
• Targeting the HIV-protease in AIDS therapy: a current clinical perspective (Q33857482) (← links)
• Efficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant library (Q34005107) (← links)
• Production of active mammalian and viral proteases in bacterial expression systems (Q34187840) (← links)
• Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector (Q34320065) (← links)
• Clinical pharmacology and pharmacokinetics of amprenavir. (Q34509359) (← links)
• Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments (Q34618267) (← links)
• Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease. (Q35125088) (← links)
• The SIVmac239 Pr55Gag isoform, SIV p43, suppresses proteolytic cleavage of Pr55Gag (Q35758211) (← links)
• Validating the vitality strategy for fighting drug resistance (Q35821952) (← links)
• Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles (Q35860937) (← links)
• A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1. (Q35871101) (← links)
• The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding (Q36046317) (← links)
• Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria (Q36649000) (← links)
• Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases (Q36780021) (← links)
• Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus (Q36782067) (← links)
• An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag (Q36797042) (← links)
• Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles (Q36807189) (← links)
• Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein. (Q36830775) (← links)
• Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus. (Q36879585) (← links)